Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Icon Plc (ICLR)

Icon Plc (ICLR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,928,599
  • Shares Outstanding, K 53,622
  • Annual Sales, $ 2,806 M
  • Annual Income, $ 373,990 K
  • 60-Month Beta 0.86
  • Price/Sales 3.15
  • Price/Cash Flow 18.96
  • Price/Book 5.84
  • Price/Earnings ttm 23.67
  • Earnings Per Share ttm 6.96
  • Most Recent Earnings 1.70 on 04/22/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 1.09
  • Number of Estimates 8
  • High Estimate 1.18
  • Low Estimate 1.01
  • Prior Year 1.69
  • Growth Rate Est. (year over year) -35.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
145.11 +14.75%
on 05/05/20
170.00 -2.05%
on 05/22/20
+8.38 (+5.30%)
since 04/22/20
3-Month
104.28 +59.68%
on 03/18/20
170.00 -2.05%
on 05/22/20
-4.47 (-2.61%)
since 02/21/20
52-Week
104.28 +59.68%
on 03/18/20
178.99 -6.97%
on 02/20/20
+27.16 (+19.49%)
since 05/22/19

Most Recent Stories

More News
The Global Real World Evidence Solution Market is expected to grow from USD 765.13 Million in 2018 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.86%

, /PRNewswire/ --

ICLR : 166.51 (+1.07%)
IBM : 118.39 (-0.61%)
MHMNF : 54.5000 (unch)
ORCL : 52.62 (+0.77%)
Pharmacovigilance Market to Hit USD 12.25 Billion by 2027; Rising Consumption of Varied Medicines by Patients to Fuel Market Growth: Fortune Business Insights(TM)

The global pharmacovigilance market size is projected to reach USD 12.25 billion by 2027, exhibiting a CAGR of 12.3% during the forecast period. Initiation of awareness campaigns to disperse information...

ICLR : 166.51 (+1.07%)
The companion diagnostics industry analysis projects the market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030

, /PRNewswire/ -- Read the full report: • What are the long-term and short-term impacts of companion diagnostics on the human health continuum?• What are the major market drivers, challenges, and...

ABT : 91.47 (+1.19%)
A : 84.98 (+5.24%)
ICLR : 166.51 (+1.07%)
ILMN : 354.70 (+1.51%)
MYGN : 14.73 (+0.27%)
QGEN : 42.99 (+0.14%)
Contract Research Organization Services Market to Exhibit a CAGR of 11.4% by 2026; Enormous Investment in R&D by Key Players to Aid Expansion, states Fortune Business Insights(TM)

The global contract research organization services market size is expected to reach USD 90,926.3 million by 2026, exhibiting a CAGR of 11.4% during the forecast period. The increasing demand for effective...

ICLR : 166.51 (+1.07%)
PRAH : 97.46 (+0.80%)
ICON plc to Present at UBS Virtual Global Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan...

ICLR : 166.51 (+1.07%)
ICON Appoints New Chief Medical Officer

ICON plc, (NASDAQ: ICLR) a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that...

ICLR : 166.51 (+1.07%)
Insights on the Worldwide Healthcare CRO Services Industry to 2025 - Featuring ICON PLC, Dassault Systemes & Syneos Health Among Others - ResearchAndMarkets.com

The "Global Healthcare CRO Services Market, by Service Type, by End User, by Therapeutic Area, by Region, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's...

DASTY : 154.2700 (+1.03%)
ICLR : 166.51 (+1.07%)
Icon PLC (ICLR) Q1 Earnings Lag Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of -1.16% and 0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ICLR : 166.51 (+1.07%)
Icon PLC: 1Q Earnings Snapshot

DUBLIN (AP) _ Icon PLC (ICLR) on Wednesday reported first-quarter net income of $91.7 million.

ICLR : 166.51 (+1.07%)
ICON Reports First Quarter 2020 Results

ICON plc (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations,...

ICLR : 166.51 (+1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ICLR with:

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

2nd Resistance Point 172.43
1st Resistance Point 169.47
Last Price 166.51
1st Support Level 164.08
2nd Support Level 161.65

See More

52-Week High 178.99
Last Price 166.51
Fibonacci 61.8% 150.45
Fibonacci 50% 141.63
Fibonacci 38.2% 132.82
52-Week Low 104.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar